Abstract
Intravitreal enzyme replacement therapy to prevent retinal disease progression in children with neuronal ceroid lipofuscinosis type 2 (CLN2): Interim safety report
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have